Reprise Biomedical
Reprise Biomedical appears in FDA public data with 0 recalls, 5 510(k) clearances, 4 FDA inspections, and 0 compliance actions on record. Its most recent FDA inspection ended on Nov 20, 2025 (No Action Indicated (NAI)). Its most recent 510(k) clearance was granted on Apr 19, 2024.
Reviewing Reprise Biomedical as a supplier? Get its full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site, in Claude, Cursor or ChatGPT.
Summary
- Total Recalls
- 0
- 510(k) Clearances
- 5
- Inspections
- 4
- Compliance Actions
- 0
Recent FDA Inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Nov 20, 2025 | Plymouth, MN | Devices | No Action Indicated (NAI) | 3010894343 |
| Jul 8, 2021 | Plymouth, MN | Devices | No Action Indicated (NAI) | 3010894343 |
| Apr 2, 2019 | Plymouth, MN | Devices | No Action Indicated (NAI) | 3010894343 |
| Sep 18, 2015 | Plymouth, MN | Devices | Voluntary Action Indicated (VAI) | 3010894343 |